Strong Funding Milestone Gateway for Cancer Research has invested over $123 million in more than 230 clinical trials globally, demonstrating a solid commitment to funding innovative cancer treatments and showcasing their capacity to allocate significant resources towards groundbreaking research.

Recent High-Profile Merger The merger with Celebrity Fight Night has elevated the organization’s visibility and expanded its network of supporters, presenting an opportunity to engage with a broader donor base and increase funding channels for future initiatives.

Awards and Recognition Receiving the Global Humanitarian Award highlights Gateway’s reputation for impactful work, making it a compelling partner for organizations seeking alignment with a trusted and recognized leader in cancer research philanthropy.

Collaborative Funding Initiatives Partnerships with entities like Conquer Cancer indicate Gateway’s openness to scientific collaborations, creating potential avenues for joint grant opportunities, co-funded research projects, and shared fundraising campaigns.

Niche Focus on Underfunded Cancers Specializing in funding early-stage clinical trials for rare and underfunded cancers positions Gateway as a key player in filling research gaps, offering prospects for companies and organizations interested in targeted cancer therapies and innovative treatment development.